Ovarian Neoplasms  >>  Triapine (3-AP)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Triapine (3-AP) / Vion, Northwestern University
NCT00081276: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Completed
2
48
US
triapine, 3-AP, OCX-191, cisplatin, CACP, CDDP, CPDD, DDP, laboratory biomarker analysis
National Cancer Institute (NCI)
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
01/07
 

Download Options